Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma.
Hotte SJ, Bjarnason GA, Heng DY, Jewett MA, Kapoor A, Kollmannsberger C, Maroun J, Mayhew LA, North S, Reaume MN, Ruether JD, Soulieres D, Venner PM, Winquist EW, Wood L, Yong JH, Saad F.
Hotte SJ, et al. Among authors: kapoor a.
Curr Oncol. 2011 Oct;18 Suppl 2(Suppl 2):S11-9. doi: 10.3747/co.v18is2.941.
Curr Oncol. 2011.
PMID: 21969807
Free PMC article.